Literature DB >> 26728995

Thrombospondin-1 differentially regulates microRNAs in vascular smooth muscle cells.

Kristopher G Maier1,2, Brian Ruhle3,4, Jeffrey J Stein3,4, Karen L Gentile5, Frank A Middleton5, Vivian Gahtan3,4.   

Abstract

Thrombospondin-1 (TSP-1) is an important regulator of vascular smooth muscle cell (VSMC) physiology and gene expression. MicroRNAs (microRNA), small molecules that regulate protein translation, have emerged as potent regulators of cell function. MicroRNAs have been shown to be involved in intimal hyperplasia, atherosclerosis, and upregulated in the vasculature in diabetes. The purpose of this study was to identify microRNAs regulated by TSP-1 in vascular smooth muscle cells (VSMCs). Human VSMCs were treated for 6 h with basal media or TSP-1 both supplemented with 0.2% FBS. Cells were then snap frozen and RNA extracted. An Affymetrix GeneChip microRNA array analysis was performed in triplicate on three separate collections. Confirmatory qrtPCR was performed. Data were analyzed by ANOVA or t test, with significance set at p < 0.05. MicroRNAs identified were subjected to KEGG pathway analysis using the DIANA tools miRPath online tool. TSP-1 upregulated 22 microRNAs and downregulated 18 microRNAs in VSMCs (p < 0.05). The most upregulated microRNA was miR-512-3p (45.12 fold). The microRNA most downregulated by TSP-1 was miR-25-5p, which was decreased by 9.61. Of note, five members of the mir-17-92 cluster were downregulated. KEGG analysis revealed that thirty-three cellular signaling pathways were impacted by these microRNAs and that nine pathways were relevant to vascular disease. MicroRNAs regulate protein expression at the level of translation and may represent a significant mechanism by which TSP-1 regulates VSMC function. Several of the microRNAs identified have a role in vascular function. The miR-17-92 cluster family, which was found to exhibit reduced expression in this study, is known to be involved in angiogenesis and vascular function. TSP-1 regulates multiple microRNAs in VSMCs adding a new layer of complexity to TSP-1 regulation of VSMC function.

Entities:  

Keywords:  Gene expression profiling; MicroRNA; Thrombospondins; Vascular smooth muscle

Mesh:

Substances:

Year:  2016        PMID: 26728995     DOI: 10.1007/s11010-015-2614-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  25 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  Immunolocalization of thrombospondin-1 in human atherosclerotic and restenotic arteries.

Authors:  R Riessen; M Kearney; J Lawler; J M Isner
Journal:  Am Heart J       Date:  1998-02       Impact factor: 4.749

3.  Downregulation of the miR-30 family microRNAs contributes to endoplasmic reticulum stress in cardiac muscle and vascular smooth muscle cells.

Authors:  Ming Chen; Guiling Ma; Yin Yue; Yu Wei; Qiang Li; Zichuan Tong; Lin Zhang; Guobin Miao; Jianjun Zhang
Journal:  Int J Cardiol       Date:  2014-02-20       Impact factor: 4.164

4.  Thrombospondin 1, fibronectin, and vitronectin are differentially dependent upon RAS, ERK1/2, and p38 for induction of vascular smooth muscle cell chemotaxis.

Authors:  Alliric I Willis; Benjamin Sadowitz; Shoichi Fuse; Kristopher G Maier; Tae S Lee; Xiu-Jie Wang; George P Tuszynski; Bauer E Sumpio; Vivian Gahtan
Journal:  Vasc Endovascular Surg       Date:  2011-01       Impact factor: 1.089

5.  Integrins alphavbeta3 and alphavbeta5 mediate VSMC migration and are elevated during neointima formation in the rat aorta.

Authors:  K Kappert; F Blaschke; W P Meehan; H Kawano; M Grill; E Fleck; W A Hsueh; R E Law; K Graf
Journal:  Basic Res Cardiol       Date:  2001-02       Impact factor: 17.165

Review 6.  The role of thrombospondin-1 in human disease.

Authors:  Nowokere Esemuede; Taeseung Lee; Daphne Pierre-Paul; Bauer E Sumpio; Vivian Gahtan
Journal:  J Surg Res       Date:  2004-11       Impact factor: 2.192

7.  MicroRNA MiR-17 retards tissue growth and represses fibronectin expression.

Authors:  Sze Wan Shan; Daniel Y Lee; Zhaoqun Deng; Tatiana Shatseva; Zina Jeyapalan; William W Du; Yaou Zhang; Jim W Xuan; Siu-Pok Yee; Vinayakumar Siragam; Burton B Yang
Journal:  Nat Cell Biol       Date:  2009-07-26       Impact factor: 28.824

8.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.

Authors:  R C Lee; R L Feinbaum; V Ambros
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

9.  Increased expression of thrombospondin-1 in vessel wall of diabetic Zucker rat.

Authors:  Olga I Stenina; Irene Krukovets; Kai Wang; Zhongmin Zhou; Farhad Forudi; Marc S Penn; Eric J Topol; Edward F Plow
Journal:  Circulation       Date:  2003-06-16       Impact factor: 29.690

Review 10.  Role of microRNAs in vascular diseases, inflammation, and angiogenesis.

Authors:  Carmen Urbich; Angelika Kuehbacher; Stefanie Dimmeler
Journal:  Cardiovasc Res       Date:  2008-06-11       Impact factor: 10.787

View more
  9 in total

1.  Micro RNA-19a suppresses thrombospondin-1 in CD35+ B cells in the intestine of mice with food allergy.

Authors:  Li-Tao Yang; Xiao-Xi Li; Shu-Qi Qiu; Lu Zeng; Lin-Jing Li; Bai-Sui Feng; Peng-Yuan Zheng; Zhi-Gang Liu; Ping-Chang Yang
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 2.  RNAi therapy to the wall of arteries and veins: anatomical, physiologic, and pharmacological considerations.

Authors:  Christoph S Nabzdyk; Leena Pradhan-Nabzdyk; Frank W LoGerfo
Journal:  J Transl Med       Date:  2017-07-28       Impact factor: 5.531

3.  Constructing a ceRNA-immunoregulatory network associated with the development and prognosis of human atherosclerosis through weighted gene co-expression network analysis.

Authors:  Yaozhong Liu; Na Liu; Qiming Liu
Journal:  Aging (Albany NY)       Date:  2021-01-17       Impact factor: 5.682

4.  MicroRNA-208a-3p participates in coronary heart disease by regulating the growth of hVSMCs by targeting BTG1.

Authors:  Dong Wang; Caiyun Yan
Journal:  Exp Ther Med       Date:  2021-11-23       Impact factor: 2.447

5.  Downregulation of microRNA-512-3p enhances the viability and suppresses the apoptosis of vascular endothelial cells, alleviates autophagy and endoplasmic reticulum stress as well as represses atherosclerotic lesions in atherosclerosis by adjusting spliced/unspliced ratio of X-box binding protein 1 (XBP-1S/XBP-1U).

Authors:  Peipei Ge; Mingxiao Gao; Juan Du; Jingbin Yu; Lei Zhang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  Proliferation of vascular smooth muscle cells under inflammation is regulated by NF-κB p65/microRNA-17/RB pathway activation.

Authors:  Dong Yang; Chen Sun; Jing Zhang; Shu Lin; Lin Zhao; Lun Wang; Ruoran Lin; Junyuan Lv; Shijie Xin
Journal:  Int J Mol Med       Date:  2017-10-25       Impact factor: 4.101

Review 7.  A myriad of roles of miR-25 in health and disease.

Authors:  Márta Sárközy; Zsuzsanna Kahán; Tamás Csont
Journal:  Oncotarget       Date:  2018-04-20

8.  Deletion of the Mir-106b~ 25 MicroRNA cluster attenuates atherosclerosis in Apolipoprotein E knockout mice.

Authors:  Jonathan Semo; Gil Chernin; Michael Jonas; Sara Shimoni; Jacob George
Journal:  Lipids Health Dis       Date:  2019-12-03       Impact factor: 3.876

9.  Exosome-Transmitted miR-25 Induced by H. pylori Promotes Vascular Endothelial Cell Injury by Targeting KLF2.

Authors:  Na Li; Shi-Feng Liu; Kai Dong; Gui-Chun Zhang; Jing Huang; Zhi-Heng Wang; Tong-Jian Wang
Journal:  Front Cell Infect Microbiol       Date:  2019-10-29       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.